Building upon the Center's focus on neuroadaptation, this Pilot Project will collect data on molecular links of excessive drinking in human subjects, examining measures theoretically related to alcoholism for which the experiments have not yet been pursued to collect supporting data. This novel experiment will collect pilot data on corticotropin-releasing factor (allostasis/stress model) and anandamide (neuronal ethanol target model) in CSF in humans. The pilot data will be used to pursue NIH funding to expand investigation in these areas. The project will enrich the Center's overall research effort by extending the knowledge of the basic nature of alcohol's action to the human, and has attracted Dr. Darko, with his experience in the measurement and psychoactive effects of peptides, as a new investigator to the area of alcohol research. The Pilot Project Component is designed as a 2-year study to compare 2 groups that differ on alcohol use. Two hypotheses will be tested: (1) individuals with increased subjective distress without alcohol (alcoholics abstinent 30 to 60 days) will have higher levels of CRF in CSF than subjects without such distress (social drinkers); and (2) subjects with exposure to alcohol (social drinkers) will have higher levels of CSF anandamide (AEA) than subjects without recent alcohol exposure (alcoholics abstinent 30 to 60 days). These results examining mechanisms in the human with this method will provide exciting bases for continuing to define the underlying molecular components of alcoholism and neuroadaptation in the human.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Comprehensive Center (P60)
Project #
5P60AA006420-21
Application #
7552581
Study Section
Special Emphasis Panel (ZAA1)
Project Start
Project End
Budget Start
2004-01-01
Budget End
2004-12-31
Support Year
21
Fiscal Year
2004
Total Cost
$75,080
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Matzeu, Alessandra; Terenius, Lars; Martin-Fardon, Remi (2018) Exploring Sex Differences in the Attenuation of Ethanol Drinking by Naltrexone in Dependent Rats During Early and Protracted Abstinence. Alcohol Clin Exp Res 42:2466-2478
Kononoff, Jenni; Melas, Philippe A; Kallupi, Marsida et al. (2018) Adolescent cannabinoid exposure induces irritability-like behavior and cocaine cross-sensitization without affecting the escalation of cocaine self-administration in adulthood. Sci Rep 8:13893
Verheij, Michel M M; Contet, Candice; Karel, Peter et al. (2018) Median and Dorsal Raphe Serotonergic Neurons Control Moderate Versus Compulsive Cocaine Intake. Biol Psychiatry 83:1024-1035
Schmeichel, Brooke E; Matzeu, Alessandra; Koebel, Pascale et al. (2018) Knockdown of hypocretin attenuates extended access of cocaine self-administration in rats. Neuropsychopharmacology 43:2373-2382
Kononoff, Jenni; Kallupi, Marsida; Kimbrough, Adam et al. (2018) Systemic and Intra-Habenular Activation of the Orphan G Protein-Coupled Receptor GPR139 Decreases Compulsive-Like Alcohol Drinking and Hyperalgesia in Alcohol-Dependent Rats. eNeuro 5:
Kreisler, A D; Mattock, M; Zorrilla, E P (2018) The duration of intermittent access to preferred sucrose-rich food affects binge-like intake, fat accumulation, and fasting glucose in male rats. Appetite 130:59-69
Varodayan, F P; Khom, S; Patel, R R et al. (2018) Role of TLR4 in the Modulation of Central Amygdala GABA Transmission by CRF Following Restraint Stress. Alcohol Alcohol 53:642-649
McClatchy, Daniel B; Yu, Nam-Kyung; Martínez-Bartolomé, Salvador et al. (2018) Structural Analysis of Hippocampal Kinase Signal Transduction. ACS Chem Neurosci :
Berger, Anthony L; Henricks, Angela M; Lugo, Janelle M et al. (2018) The Lateral Habenula Directs Coping Styles Under Conditions of Stress via Recruitment of the Endocannabinoid System. Biol Psychiatry 84:611-623
Mason, Barbara J; Quello, Susan; Shadan, Farhad (2018) Gabapentin for the treatment of alcohol use disorder. Expert Opin Investig Drugs 27:113-124

Showing the most recent 10 out of 211 publications